Filing Details
- Accession Number:
- 0001466049-10-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-13 12:00:00
- Reporting Period:
- 2010-01-11
- Filing Date:
- 2010-01-13
- Accepted Time:
- 2010-01-13 16:34:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1322505 | Biodel Inc | BIOD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1281446 | Great Point Partners Llc | 165 Mason Street 3Rd Floor Greenwich CT 06830 | Yes | No | No | No | |
1397513 | David Kroin | C/O Biodel Inc 100 Saw Mill Road Danbury CT 06810 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-11 | 35,200 | $5.01 | 1,126,443 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-12 | 34,010 | $5.06 | 1,092,433 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2009.
- This transaction was executed in multiple trades at prices ranging from $5.00 to 5.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $5.00 to 5.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The amount shown represents the beneficial ownership of the issuer's securities by Great Point Partners I, L.P., which may be deemed attributable to Mr. Kroin because Mr. Kroin is a co-founder and managing director of Great Point Partners I, L.P. Mr. Kroin serves as a director of the issuer as a representative of Great Point Partners I, L.P., and accordingly Great Point Partners I, L.P. may be deemed to be a director by deputization. Mr. Kroin disclaims beneficial ownership of the shares except to the extent of his pecuinary interest therein.